The Food and Drug Administration (FDA) has approved Andembry ® (garadacimab-gxii) for prophylactic use to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years ...

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

The former ACIP members are “deeply concerned that these destabilizing decisions may roll back the achievements of US immunization policy.” ...

Similar increases observed for higher-order births; increase in mean age at first birth seen in all racial and ethnic groups.

Heaviest burden born by regions with high sociodemographic index, apart from Japan, which had declining trends.

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

The increase suggests that the variant is spreading, and spreading fast. HealthDay News — A new COVID-19 variant that led to a spike in hospital cases across parts of Asia may now account for more ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

HealthDay News — Mindfulness (MI) and transcranial direct current stimulation (tDCS) of the dorsolateral prefrontal cortex offer therapeutic benefit for reducing situational urgency urinary ...

Pediatricians should provide their patients with their contraceptive of choice, if no medical contraindications exist.